← Insider Monitor
ORKA
Oruka Therapeutics, Inc.
Recent activity from public SEC and congressional filings.
11
Insider trades
0
Congress trades
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Quinlan Paul TGeneral Counsel | Sell | $1.59M | 14,696at $107.97 | Aug 14, 2026 |
| Quinlan Paul TGeneral Counsel | Sell | $1.12M | 10,434at $107.14 | Aug 14, 2026 |
| Quinlan Paul TGeneral Counsel | Sell | $1.11M | 10,200at $109.11 | Aug 14, 2026 |
| Quinlan Paul TGeneral Counsel | Sell | $1.01M | 9,193at $110.00 | Aug 14, 2026 |
| Quinlan Paul TGeneral Counsel | Sell | $428K | 3,847at $111.14 | Aug 14, 2026 |
| Quinlan Paul TGeneral Counsel | Sell | $385K | 3,630at $106.05 | Aug 14, 2026 |
| Agarwal ArjunSenior Vice President, Finance | Sell | $256K | 2,358at $108.46 | Aug 13, 2026 |
| Agarwal ArjunSenior Vice President, Finance | Sell | $231K | 2,142at $107.71 | Aug 13, 2026 |
| Agarwal ArjunSenior Vice President, Finance | Sell | $225K | 2,132at $105.57 | Aug 13, 2026 |
| Agarwal ArjunSenior Vice President, Finance | Sell | $220K | 2,100at $104.67 | Aug 13, 2026 |
| Agarwal ArjunSenior Vice President, Finance | Sell | $135K | 1,268at $106.63 | Aug 13, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
No recent congressional disclosures found for ORKA.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable ORKA activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.